During the COVID-19 pandemic, patients with prolonged aPTT at baseline and exhibiting heparin resistance should be focused on monitoring anti-Xa levels, while patients with disseminated intravascular coagulation (DIC) or sepsis should be focused on antithrombin indicators. The gene discussed is TNXA; the disease is Sepsis.